Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
80.44B | 80.49B | 80.47B | 80.85B | 86.79B | 76.56B |
Gross Profit | |||||
25.90B | 26.20B | 25.91B | 25.24B | 30.86B | 26.55B |
EBIT | |||||
3.50B | 3.71B | 3.91B | 5.00B | 11.30B | 7.93B |
EBITDA | |||||
6.95B | 8.86B | 10.64B | 10.42B | 13.92B | 11.62B |
Net Income Common Stockholders | |||||
3.71B | 4.15B | 5.45B | 5.86B | 7.79B | 6.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
17.99B | 21.06B | 16.42B | 9.56B | 22.69B | 19.88B |
Total Assets | |||||
160.24B | 157.76B | 164.82B | 155.94B | 155.46B | 150.06B |
Total Debt | |||||
5.73B | 5.59B | 5.79B | 2.52B | 3.08B | 3.05B |
Net Debt | |||||
-12.26B | -15.47B | -10.62B | -7.04B | -10.81B | -6.33B |
Total Liabilities | |||||
33.63B | 33.40B | 35.40B | 35.36B | 36.88B | 35.61B |
Stockholders Equity | |||||
126.61B | 124.36B | 129.42B | 120.58B | 118.58B | 114.45B |
Cash Flow | Free Cash Flow | ||||
0.00 | 7.50B | 4.59B | -9.55B | 5.66B | 3.50B |
Operating Cash Flow | |||||
0.00 | 11.54B | 7.91B | -7.59B | 8.43B | 6.60B |
Investing Cash Flow | |||||
0.00 | -2.14B | -1.06B | 853.00M | -2.39B | -3.33B |
Financing Cash Flow | |||||
0.00 | -4.71B | -533.00M | -6.35B | -2.90B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €165.01B | 14.98 | 10.97% | 2.65% | 7.11% | -0.53% | |
75 Outperform | ¥107.14B | 14.41 | 2.73% | 8.95% | 4.60% | ||
74 Outperform | $85.01B | 16.88 | 15.32% | 0.02% | -2.62% | 26.11% | |
71 Outperform | ¥152.06B | 4.89 | 30.22% | 1.81% | 5.27% | ― | |
71 Outperform | ¥89.70B | 20.69 | 4.98% | 0.03% | -23.96% | ||
69 Neutral | $594.36B | 10.84 | 6.70% | 4.15% | 3.72% | 6.31% | |
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% |